COUNTRY CONDO S LIMITED (COUNCODOS) financials
COUNTRY CONDO S LIMITED (COUNCODOS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Country Condo's Limited is a Hyderabad-based real-estate company that procures land, develops residential plotted layouts and sells plots after registration; it also undertakes allied site-development work. Originally incorporated as Neocure Therapeutics Pvt Ltd in 1987, it diversified from pharmaceuticals and adopted the present name in December 2006.[1][2]
- Market Cap: ₹48.9Cr.
- Current Price: ₹6.30
- Stock P/E: 78.8
- ROE: 2.32%
- ROCE: 4.17%
- Book Value: ₹3.31
- Dividend Yield: 0.00%
- 52W High / Low: ₹7.85/3.71
In Jun 2026, COUNTRY CONDO S LIMITED (COUNCODOS) reported sales ₹4.10 Cr and net profit ₹0.16 Cr.
Annual TTM: sales ₹18.04 Cr, net profit ₹0.62 Cr.
Shareholding: Promoters 53.86% (Jun 2026), FIIs 0.11% (Jun 2026), Public 46.03% (Jun 2026), No. of Shareholders 27,752% (Jun 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4.99 | 4.90 | 2.62 | 3.54 | 5.83 | 4.43 | 3.68 | 4.10 |
| Expenses | 4.72 | 4.67 | 2.44 | 3.32 | 5.51 | 4.29 | 3.34 | 3.87 |
| Operating Profit | 0.27 | 0.23 | 0.18 | 0.22 | 0.32 | 0.14 | 0.34 | 0.23 |
| OPM % | 5.41% | 4.69% | 6.87% | 6.21% | 5.49% | 3.16% | 9.24% | 5.61% |
| Other Income | 0.03 | 0.04 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |
| Profit before tax | 0.23 | 0.21 | 0.15 | 0.18 | 0.29 | 0.10 | 0.30 | 0.20 |
| Tax % | 30.43% | 28.57% | 40.00% | 22.22% | 31.03% | 30.00% | 40.00% | 25.00% |
| Net Profit | 0.16 | 0.15 | 0.09 | 0.14 | 0.21 | 0.07 | 0.18 | 0.16 |
| EPS in Rs | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 17.89 | 12.44 | 21.93 | 21.10 | 25.32 | 16.71 | 17.48 | 18.04 |
| Expenses | 16.23 | 11.31 | 22.45 | 19.75 | 23.66 | 15.55 | 16.28 | 17.01 |
| Operating Profit | 1.66 | 1.13 | -0.52 | 1.35 | 1.66 | 1.16 | 1.20 | 1.03 |
| OPM % | 9.28% | 9.08% | -2.37% | 6.40% | 6.56% | 6.94% | 6.86% | 5.71% |
| Other Income | 0.12 | 0.16 | 3.90 | 0.15 | 0.83 | 0.10 | 0.01 | 0.01 |
| Interest | 0.58 | 0.32 | 0.23 | 0.26 | 0.38 | 0.26 | 0.19 | 0.00 |
| Depreciation | 0.36 | 0.34 | 0.17 | 0.15 | 0.16 | 0.16 | 0.15 | 0.15 |
| Profit before tax | 0.84 | 0.63 | 2.98 | 1.09 | 1.95 | 0.84 | 0.87 | 0.89 |
| Tax % | 27.38% | 25.40% | 15.10% | 25.69% | 17.44% | 28.57% | 32.18% | — |
| Net Profit | 0.62 | 0.47 | 2.53 | 0.81 | 1.61 | 0.60 | 0.59 | 0.62 |
| EPS in Rs | 0.08 | 0.06 | 0.33 | 0.10 | 0.21 | 0.08 | 0.08 | 0.08 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.76 | 7.76 | 7.76 | 7.76 | 7.76 | 7.76 | 7.76 | 7.76 |
| Reserves | 10.71 | 11.33 | 11.80 | 14.32 | 15.13 | 16.74 | 17.34 | 17.93 |
| Borrowings | 1.09 | 1.06 | 0.31 | 0.11 | 1.66 | 1.95 | 0.05 | 0.00 |
| Other Liabilities | 7.27 | 10.35 | 10.94 | 8.94 | 8.62 | 7.21 | 12.04 | 19.30 |
| Total Liabilities | 26.83 | 30.50 | 30.81 | 31.13 | 33.17 | 33.66 | 37.19 | 44.99 |
| Fixed Assets | 5.09 | 5.07 | 4.59 | 1.26 | 1.35 | 0.78 | 0.65 | 0.53 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 21.74 | 25.43 | 26.22 | 29.87 | 31.82 | 32.88 | 36.54 | 44.46 |
| Total Assets | 26.83 | 30.50 | 30.81 | 31.13 | 33.17 | 33.66 | 37.19 | 44.99 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.87 | 1.90 | -0.66 | -1.47 | -1.64 | -0.92 | -1.34 | 0.49 |
| Cash from Investing Activity | -0.31 | -0.34 | 0.14 | 3.16 | -0.24 | 0.41 | -0.03 | -0.03 |
| Cash from Financing Activity | -0.42 | -0.13 | -0.83 | -0.22 | 1.52 | 0.16 | -1.97 | -0.05 |
| Net Cash Flow | 0.14 | 1.43 | -1.35 | 1.47 | -0.36 | -0.36 | -3.35 | 0.42 |
| Free Cash Flow | 0.56 | 1.56 | -0.53 | 1.69 | -1.88 | -0.51 | -1.37 | 0.46 |
| CFO/OP | 61% | 114% | -58% | 283% | -121% | -55% | -116% | 41% |
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 53.86% | 53.86% | 53.86% | 53.86% | 53.86% | 53.86% | 53.86% | 53.86% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Public | 46.12% | 46.13% | 46.13% | 46.03% | 46.02% | 46.02% | 46.02% | 46.03% |
| No. of Shareholders | 25,771 | 27,138 | 28,046 | 28,317 | 28,306 | 28,270 | 27,931 | 27,752 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 392.40 | 729.15 | 1,373.63 | 710.82 | 1,002.16 | 784.76 | 2,158.04 | 3,399.80 |
| Days Payable | 4.38 | 0.85 | 1.39 | 0.31 | 0.00 | 0.30 | 0.00 | 0.00 |
| Cash Conversion Cycle | 388.02 | 728.31 | 1,372.23 | 710.51 | 1,002.16 | 784.47 | 2,158.04 | 3,399.80 |
| Working Capital Days | 212.21 | 224.43 | 366.76 | 273.13 | 303.76 | 288.45 | 524.89 | 507.62 |
| ROCE % | 6.07% | 7.15% | 4.70% | -2.71% | 5.78% | 6.47% | 4.26% | 4.17% |
Country Condo S Limited
₹48.9Cr.
₹6.30
₹7.85/3.71
78.8
Country Condo's Limited is a Hyderabad-based real-estate company that procures land, develops residential plotted layouts and sells plots after registration; it also undertakes allied site-development work. Originally incorporated as Neocure Therapeutics Pvt Ltd in 1987, it diversified from pharmaceuticals and adopted the present name in December 2006.[1][2]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of COUNTRY CONDO S LIMITED (COUNCODOS)?
The reported market capitalisation for COUNTRY CONDO S LIMITED (COUNCODOS) is ₹48.9Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of COUNCODOS?
The current price shown for COUNTRY CONDO S LIMITED (COUNCODOS) on Fincrux is ₹6.30 with a 52-week high/low of ₹7.85/3.71.
What is the P/E ratio of COUNTRY CONDO S LIMITED (COUNCODOS)?
The stock P/E for COUNTRY CONDO S LIMITED (COUNCODOS) is 78.8 on Fincrux, with ROE at 2.32% and ROCE at 4.17%.
What were COUNCODOS latest quarterly results?
For Jun 2026, COUNTRY CONDO S LIMITED (COUNCODOS) reported sales ₹4.10 Cr and net profit ₹0.16 Cr (figures in ₹ crore unless noted).
What are COUNCODOS annual sales and net profit?
For TTM, COUNTRY CONDO S LIMITED (COUNCODOS) shows sales of ₹18.04 Cr and net profit of ₹0.62 Cr on the Fincrux profit & loss statement.
Who owns COUNTRY CONDO S LIMITED (COUNCODOS)?
Latest shareholding for COUNTRY CONDO S LIMITED (COUNCODOS) on Fincrux: Promoters 53.86% (Jun 2026), FIIs 0.11% (Jun 2026), Public 46.03% (Jun 2026), No. of Shareholders 27,752% (Jun 2026).
Where can I find COUNTRY CONDO S LIMITED (COUNCODOS) financials?
COUNTRY CONDO S LIMITED (COUNCODOS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show COUNCODOS balance sheet and cash flow?
Yes. The COUNTRY CONDO S LIMITED (COUNCODOS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.